Literature DB >> 16672637

Catastrophic antiphospholipid syndrome.

Setu K Vora1, Ronald A Asherson, Doruk Erkan.   

Abstract

Catastrophic antiphospholipid syndrome is a rapidly progressive life-threatening disease that causes multiple organ thromboses and dysfunction in the presence of antiphospholipid antibodies. A high index of clinical suspicion and careful investigation are required to make an early diagnosis so that treatment with anticoagulation and corticosteroids can be initiated; plasma exchange and/or intravenous immunoglobulins can be added if the life-threatening condition persists. Despite aggressive treatment and intensive care unit management, patients with catastrophic antiphospholipid syndrome have a 48% mortality rate, primarily attributable to cardiopulmonary failure. This article reviews the current information on the etiopathogenesis, clinical manifestations, diagnosis, management, and prognosis of catastrophic antiphospholipid syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16672637     DOI: 10.1177/0885066606287041

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  15 in total

1.  Delayed catastrophic antiphospholipid syndrome after massive cerebral infarction.

Authors:  Wei Hsi Chen; Hung Sheng Lin; Yi Fen Kao; Jia Shou Liu
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 2.  Clinical and laboratory features of the catastrophic antiphospholipid syndrome.

Authors:  Ljudmila Stojanovich; Dragomir Marisavljevic; Jozef Rovensky; Aleksandra Djokovich; Darina Kozáková; Nikola Milinic
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

3.  Catastrophic antiphospholipid syndrome triggered by sepsis.

Authors:  Susan Kim; Neal K Moskowitz; Edward F DiCarlo; Anne R Bass; Doruk Erkan; Michael D Lockshin
Journal:  HSS J       Date:  2008-12-19

4.  Catastrophic antiphospholipid antibody syndrome as a first manifestation of primary antiphospholipid antibody syndrome in a middle-aged man.

Authors:  Nazrul Hassan Jafry; Muhammed Mubarak; Ejaz Ahmed; Fazal Akhtar
Journal:  CEN Case Rep       Date:  2020-01-27

5.  Urgent plasma exchange: how, where and when.

Authors:  Gianpaolo Russi; Piero Marson
Journal:  Blood Transfus       Date:  2011-07-18       Impact factor: 3.443

Review 6.  Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome.

Authors:  Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

Review 7.  Intravenous immunoglobulin therapy in rheumatic diseases.

Authors:  Jagadeesh Bayry; Vir Singh Negi; Srini V Kaveri
Journal:  Nat Rev Rheumatol       Date:  2011-05-10       Impact factor: 20.543

Review 8.  Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome.

Authors:  Panagiotis Tsirigotis; George Mantzios; Vassiliki Pappa; Konstantinos Girkas; George Salamalekis; Angellos Koutras; Vassiliki Giannopoulou; Konstantina Spirou; Alexia Balanika; Sotirios Papageorgiou; Anthi Travlou; John Dervenoulas
Journal:  Rheumatol Int       Date:  2007-06-19       Impact factor: 2.631

Review 9.  Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse.

Authors:  Silvia Bucciarelli; Doruk Erkan; Gerard Espinosa; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 10.  Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease.

Authors:  Cassyanne L Aguiar; Doruk Erkan
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-12       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.